Elevance Health Inc/ US0367521038 /
12/26/2024 10:10:00 PM | Chg. +0.7200 | Volume | Bid2:00:00 AM | Ask2:00:00 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
373.6600USD | +0.19% | 1.25 mill. Turnover: 277.08 mill. |
370.0500Bid Size: 400 | 378.4800Ask Size: 100 | 86.66 bill.USD | 1.58% | 14.72 |
Assets
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 1,977.9000 | 2,174.9000 | 2,735 | 3,133 | 3,483 | ||||||
Intangible Assets | 7,964.9000 | 8,368.4000 | 9,007 | 8,674 | 9,405 | ||||||
Long-Term Investments | 2,796.3000 | 3,937.4000 | 4,213 | 4,733 | 4,847 | ||||||
Fixed Assets | 30,768.2000 | 34,277.2000 | 37,250 | 38,420 | 40,864 | ||||||
Inventories | - | - | - | - | - | ||||||
Accounts Receivable | 14,426.9000 | 14,978.2000 | 9,311 | 10,553 | 10,958 | ||||||
Cash and Cash Equivalents | 4,075.3000 | 3,608.9000 | 3,934 | 4,937 | 5,741 | ||||||
Current Assets | 34,314.9000 | 36,262.8000 | 34,321 | 39,033 | 45,751 | ||||||
Total Assets | 65,083.1000 | 70,540 | 71,571 | 77,453 | 86,615 |
Liabilities
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 11,907.5000 | 13,015.9000 | 12,413 | 13,040 | 16,852 | ||||||
Long-term debt | 14,358.5000 | 17,382.2000 | 17,217 | 17,787 | 19,335 | ||||||
Liabilities to Banks | 440 | 1,275 | 1,145 | 700 | 0.0000 | ||||||
Provisions | 3,446 | 2,373.8000 | 2,666 | 2,901 | 2,019 | ||||||
Liabilities | 39,982.7000 | 44,037.1000 | 43,030 | 45,725 | 53,416 | ||||||
Share Capital | 2.6000 | 2.6000 | 3 | 3 | 3 | ||||||
Total Equity | 25,100.4000 | 26,502.9000 | 28,541 | 31,728 | 33,199 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 65,083.1000 | 70,540 | 71,571 | 77,453 | 86,615 |
Income Statement
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 84,863 | 90,039.4000 | 92,105 | 104,213 | 121,867 | ||||||
Depreciation (total) | 192.3000 | 168.4000 | 358 | 338 | 361 | ||||||
Operating Result | 4,801.7000 | 4,175.4000 | 5,426 | 5,999 | 6,360 | ||||||
Interest Income | -723 | -739 | -753 | -746 | -784 | ||||||
Income Before Taxes | 4,555.4000 | 3,963.8000 | 5,068 | 5,985 | 6,238 | ||||||
Income Taxes | 2,085.6000 | 121 | 1,318 | 1,178 | 1,666 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | 2,469.8000 | 3,842.8000 | 3,750 | 4,807 | 4,572 |
Per Share
Cash Flow
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 3,204.5000 | 4,184.8000 | 3,827 | 6,061 | 10,688 | ||||||
Cash Flow from Investing Activities | -513.9000 | -5,082.4000 | -1,259 | -2,792 | -7,324 | ||||||
Cash Flow from Financing | -732.9000 | 426.9000 | -2,241 | -2,266 | -2,567 | ||||||
Decrease / Increase in Cash | 1,961.8000 | -466.4000 | 325 | 1,003 | 804 | ||||||
Employees | 53,000 | 56,000 | 63,900 | 70,600 | 83,400 |